Periprocedural antithrombotics dangerous for endovascular stroke treatment - Video

Published On 2022-03-10T17:15:52+05:30 | Updated On 10 March 2022 5:15 PM IST

Overview

Stroke treatment is very difficult. Antithrombotics are dangerous during stroke thrombectomy, according to a recent study published in the Lancet. Therefore giving Antithrombotics like IV aspirin and/or unfractionated heparin during endovascular stroke treatment does not seem to be a good idea reveals the MR CLEAN-MED trial.

Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of antithrombotics for this indication are unknown. They, therefore, aimed to assess the safety and efficacy of intravenous aspirin, unfractionated heparin, both, or neither started during endovascular treatment in patients with ischaemic stroke.

For more information check out the full story on the link below:

Antithrombotics Administration During Endovascular Stroke Treatment Not Entirely Safe: Lancet

Speakers

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751